However, some people develop inhibitors (antibodies) to them and, as a result, become resistant to further treatment. The presence of inhibitors in a person with haemophilia, the amount (titer) of that inhibitor, and whether the person is a low or a high responder are important determinants of immediate and future therapy.
Treating acquired haemophilia
The type of treatment used to control the bleeding depends on the severity of the bleed and the strength of the inhibitor in the blood.
Last updated: March 2009
CAID/SUEC/HAEM28
|